Networking Pharmaceutical Pharmaceutical manufacturing Specialization 
Pharma Marketing Network
JANUARY 18, 2023
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.
Impetus Digital
NOVEMBER 23, 2023
In these online programs, a handful of carefully selected KOLs attending the congress are asked to summarize abstracts that will be of special interest to other healthcare providers from their country/region or specialty. Some want to attend live meetings (whether web-based, hybrid, or in person) to be able to network “face-to-face.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 16, 2022
The UN Special Rapporteur on contemporary forms of racism, E. Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceutical companies selling the treatments and vaccines were agreed under terms of confidentiality.
pharmaphorum
OCTOBER 26, 2022
Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An
Pharmaceutical Technology
SEPTEMBER 15, 2022
It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region. The post The cluster effect: Connectivity and collaboration in life sciences hubs appeared first on Pharmaceutical Technology.
Expert insights. Personalized for you.
52 
Let's personalize your content